FOI 7115 - Biologic drugs in Gastroenterology

Date: 18 February 2022 to 18 February 2025

Could you please provide the numbers of patients treated in the last 3 months by the Gastroenterology department for any medical condition, and if possible, for Ulcerative Colitis, with the following biologic drugs:

Treatments

Total Gastroenterology Patients

Ulcerative Colitis Patients

Adalimumab - Humira

 

 

Adalimumab Biosimilar

 

 

Filgotinib

 

 

Golimumab

 

 

Infliximab - Remicade

 

 

Infliximab Biosimilar

 

 

Ozanimod

 

 

Tofacitinib

 

 

Ustekinumab

 

 

Vedolizumab

 

 

 

  • Request ID:
    7115
  • Category:
    Clinical - Drugs
  • Response:

    February 2022

    Thank you for your recent request under the Freedom of Information Act 2000.

     

    The information you have requested is as follows:

     

    Could you please provide the numbers of patients treated in the last 3 months by the Gastroenterology department for any medical condition, and if possible, for Ulcerative Colitis, with the following biologic drugs:

    Treatments

    Total Gastroenterology Patients

    Ulcerative Colitis Patients

    Adalimumab - Humira

     

     

    Adalimumab Biosimilar

     

     

    Filgotinib

     

     

    Golimumab

     

     

    Infliximab - Remicade

     

     

    Infliximab Biosimilar

     

     

    Ozanimod

     

     

    Tofacitinib

     

     

    Ustekinumab

     

     

    Vedolizumab

     

     

     

     Please see below data held for Gastroenterology patients.  The Trust can provide the number of patients, but unable to provide the indication that the drug was prescribed for as this is not recorded against pharmacy data.  Therefore we are unable to advise how many patients were issued drugs for ulcerative colitis.  If the drug is not listed, it is because it has not been issued. 

    Drug Name, Strength and Form

    Number of Patients

    HOMECARE ADALIMUMAB (AMGEVITA) 40 mg in 0.8ml Pre-filled Pen

    <5

    HOMECARE ADALIMUMAB (HUMIRA) 40 mg in 0.4ml Pre-filled Pen

    12

    HOMECARE ADALIMUMAB (IMRALDI) 40 mg in 0.8ml Pre-filled Pen

    105

    HOMECARE GOLIMUMAB (SIMPONI) 100 mg Pre-filled Pen

    <5

    HOMECARE GOLIMUMAB (SIMPONI) 50 mg Pre-filled Pen

    <5

    HOMECARE INFLIXIMAB (REMSIMA) 120 mg Pre-filled Pen

    7

    HOMECARE TOFACITINIB (XELJANZ) 5 mg Tablets

    <5

    HOMECARE USTEKINUMAB (STELARA) 90 mg in 1ml Pre-filled Syringe

    12

    HOMECARE VEDOLIZUMAB (ENTYVIO SC) Pre-filled Pen 108 mg in 0.68ml for SUBCUTANEOUS Injection

    10

    inFLIXimab (INFLECTRA) 100 mg Intravenous Infusion

    <5

    inFLIXimab (REMICADE) 100 mg Intravenous Infusion

    <5

    inFLIXimab (REMSIMA) 100 mg Intravenous Infusion

    67

    USTEKINUMAB 130 mg Solution for Infusion Vial

    5

    VEDOLIZUMAB 300 mg Powder for Solution Infusion

    34